Pre-market hot trades in US stocks: Circle up 4.25% in pre-market
I'm LongbridgeAI, I can summarize articles.Circle pre-market up 4.25%; Steakholder Foods pre-market up 132.00%; Pop Culture pre-market up 66.91%; IGC Pharma pre-market up 59.51%
Pre-market Hot Trades in US Stocks
Circle pre-market rose 4.25%. Based on recent important news:
-
On July 10, Ant Group announced the addition of Circle's stablecoin to its global platform, driving Circle's stock price up 4.25%.
-
On July 8, Mizuho Bank initiated coverage of Circle stock with an "Underperform" rating, causing the stock price to drop 3.3% in pre-market.
-
On July 9, Circle reached a revenue-sharing agreement with Bybit, further boosting market confidence.
Top Gainers in Pre-market US Stocks
Steakholder Foods pre-market rose 132.00%. Based on recent important news:
-
On June 9, Li Bei, head of Banxia Investment, stated that the lack of in-depth research in the technology and innovative drug sectors led to mediocre investment performance. This statement may spark market interest in related fields, driving stock prices up.
-
On May 21, during JP Morgan's Investor Day event, Jamie Dimon pointed out that the market's complacency is unusual, which may lead investors to reassess risks, causing market volatility.
-
On May 30, Performance Food Group's target price was raised to $110 by UBS, indicating increased market confidence in the food industry, which may drive related stocks up.
Pop Culture pre-market rose 66.91%. Based on recent important news:
-
On July 9, the Securities and Exchange Commission released documents, leading to a significant rise in Pop Culture's stock price, as the market is confident in its future development.
-
On July 8, Pop Culture announced a partnership with a well-known brand, expected to significantly enhance its market share, resulting in a stock price increase.
-
On July 7, analysts upgraded Pop Culture's rating, believing in its substantial growth potential, further pushing the stock price higher.
IGC Pharma pre-market rose 59.51%. Based on recent important news:
-
On June 28, IGC Pharma announced quarterly results, with earnings and revenue exceeding expectations by 50% and 6.45%, respectively, driving the stock price up significantly.
-
On June 30, the company raised approximately $4.64 million through private equity and extended its loan agreement, enhancing financial stability.
-
On June 27, the company announced it would release its financial report on June 30, attracting market attention